美国 · 股市与财经 · Investor's Business Daily

Uniqure Plummets 37% On Another Shocking Twist For Its Huntington's Drug

来源：Investor's Business Daily · 美国 1 天前

Uniqure stock crashed Tuesday on a disappointing four-year update for its gene therapy in patients with Huntington's disease.

在 Investor's Business Daily 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.investors.com)

推荐阅读

Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline

E.E.O.C. Sues Harvard for Data on Diversity in Hiring Practices

Business Insider

15 US colleges now cost more than $100,000 a year. See the list, ranked by cost of attendance.

Trump's meeting with tech leaders leaves AI safety more unsettled than ever

Open USD takes on Tether, Circle with a different stablecoin model that's 'building money'

The 'Gen Z stare' is telling us something important about today's economy